Mindray Ultrasound Systems at RSNA - Analyst Blog
29 Novembre 2011 - 6:54PM
Zacks
Leading Chinese medical devices maker Mindray Medical
International Limited (MR) will unveil a new ultrasound
system at the ongoing Radiology Society of North America (“RSNA”)
annual meet in Chicago. The new system dubbed DC-T6 is a high
performance imaging platform with a user-friendly, compact mobile
design.
The affordable DC-T6 sports a high-resolution, 15-inch TFT
monitor and a swivel and height-adjustable control panel. It also
features iPower, an embedded battery, which offers up to two hours
of interruptible scanning when power is not available. Among other
special features, DC-T6 offers a real-time 4D and panoramic
imaging.
Besides DC-T6, Mindray will also showcase significant
enhancements for its M7 and DC-7 ultrasound platforms at the RSNA
meet. The company will unveil new upgrades to the DC-7 system
including an iPage 3D volume data series, a 3D/4D spatial-cutting
tool and a new transducer.
For M7, the enhancements include iNeedle, a new needle detection
technology for interventional and vascular access procedures.
Moreover, Mindray will feature the iZoom software which enables
more accurate and clear visualization of patient anatomy from a
distance.
The high-end segment of the ultrasound business is growing at a
brisk pace as more and more healthcare providers acquire
sophisticated capability but in compact and portable form.
Mindray is a bellwether in the Chinese MedTech industry with a
solid international presence. The company maintains a decent
product pipeline and brings out several new products every
year.
Mindray remains committed to providing clinicians with the
latest technology that enhances patient care. The company’s
state-of-the-art ultrasound systems are enjoying healthy traction
in North America.
Besides China, Mindray operates in North America, Europe and
other Asian countries. The company competes with global devices
manufacturers such as General Electric (GE),
Philips (PHG) and Siemens (SI).
We currently have a long-term Neutral rating on Mindray. The stock
currently retains a Zacks #3 Rank, which translates into a
short-term Hold recommendation.
GENL ELECTRIC (GE): Free Stock Analysis Report
MINDRAY MEDICAL (MR): Free Stock Analysis Report
KONINKLIJKE PHL (PHG): Free Stock Analysis Report
SIEMENS AG-ADR (SI): Free Stock Analysis Report
Zacks Investment Research
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Lug 2023 a Lug 2024